Delaware
(State or other jurisdiction of incorporation) |
000-23186
(Commission File Number) |
62-1413174
(IRS Employer Identification #) |
On February 2, 2005, the Company issued a news release announcing its financial results for the quarter and year ended December 31, 2004. A copy of the news release is furnished as exhibit 99.1 hereto and is incorporated by reference into Item 9.01 of Form 8-K.
Exhibit No. | Description | ||
99.1 | Press release dated February 2, 2005 entitled BioCryst Reports Fourth Quarter and Year-End 2004 Financial Results |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 2, 2005 | BioCryst Pharmaceuticals,
Inc. By: /s/ Michael A. Darwin Michael A. Darwin Chief Financial Officer and Chief Accounting Officer |
Item | Description | ||
99.1 | Press release dated February 2, 2005 entitled BioCryst Reports Fourth Quarter and Year-End 2004 Financial Results |